Trademark: 90175255
Word
TREGABLE
Status
Dead
Status Code
606
Status Date
Monday, December 18, 2023
Serial Number
90175255
Mark Type
4000
Filing Date
Friday, September 11, 2020
Published for Opposition
Tuesday, May 25, 2021
Abandoned Date
Monday, December 18, 2023

Trademark Owner History
BOUNCE MERGER SUB II, LLC - 1st New Owner After Publication
TeraImmune, Inc. - Owner At Publication

Classifications
40 Custom manufacturing services for pharmaceutical products; providing technical information in the field of pharmaceutical manufacturing; custom manufacturing of pharmaceuticals
44 Providing medical information in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; providing a website featuring medical information in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; medical consulting in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; medical services; veterinary services; medical services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes; reinsertion of cells into human and animal patients for medical purposes; providing medical and therapy advice and consultancy in the field of medical and veterinary therapies; providing cancer therapy advice and consultancy
42 Medical and pharmaceutical research and development services; scientific research and development services in the medical field; providing medical and scientific research information in the medical field; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing medical and scientific research information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; scientific research and development services in the field of regulatory t-cell and chimeric antigen receptor therapy; scientific research and development services in the field of new cancer therapies; medical and veterinary research services, namely, the manipulation of cells within a laboratory or research facility to enable the cells to be used for therapeutic purposes; scientific research in human and animal gene therapy; scientific research into vectors and preparations for manipulating and adapting human and animal cells;scientific and medical research consultancy relating to all the aforesaid services

Trademark Events
Dec 18, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Dec 18, 2023
Abandonment - No Use Statement Filed
Oct 5, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
Oct 5, 2023
Teas Change Of Correspondence Received
Oct 5, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 5, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 5, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 5, 2023
Teas Change Of Owner Address Received
Jul 26, 2023
Automatic Update Of Assignment Of Ownership
May 11, 2023
Notice Of Approval Of Extension Request E-Mailed
May 9, 2023
Sou Extension 3 Granted
May 9, 2023
Sou Extension 3 Filed
May 9, 2023
Sou Teas Extension Received
Nov 18, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 16, 2022
Sou Extension 2 Granted
Nov 16, 2022
Sou Extension 2 Filed
Nov 16, 2022
Sou Teas Extension Received
Apr 20, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 18, 2022
Sou Extension 1 Granted
Apr 18, 2022
Sou Extension 1 Filed
Apr 18, 2022
Sou Teas Extension Received
Apr 15, 2022
Teas Change Of Correspondence Received
Apr 15, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 15, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 16, 2021
Noa E-Mailed - Sou Required From Applicant
Oct 3, 2021
Extension Of Time To Oppose Process - Terminated
Jul 20, 2021
Changes/Corrections After Pub Approval Entered
Jul 20, 2021
Assigned To Petition Staff
Jul 2, 2021
Teas Post Publication Amendment Received
May 25, 2021
Extension Of Time To Oppose Received
May 25, 2021
Official Gazette Publication Confirmation E-Mailed
May 25, 2021
Published For Opposition
May 5, 2021
Notification Of Notice Of Publication E-Mailed
Apr 18, 2021
Approved For Pub - Principal Register
Apr 16, 2021
Teas/Email Correspondence Entered
Apr 16, 2021
Correspondence Received In Law Office
Apr 16, 2021
Teas Response To Office Action Received
Jan 29, 2021
Notification Of Non-Final Action E-Mailed
Jan 29, 2021
Non-Final Action E-Mailed
Jan 29, 2021
Non-Final Action Written
Jan 21, 2021
Assigned To Examiner
Oct 20, 2020
New Application Office Supplied Data Entered
Sep 15, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24